Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops 3rd GBHI conference – all speakers confirmed Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Clinical Monitoring ICF HTA Phase I Unit Clinical study Consultancy Scientific expertise Eye disease Healthy subjects NIS Safety SAS Phase II CDM MMM Auditing Feasibility Data management Absorption windows Endpoint Standard operating procedure Cough Gynaecological trials Contraception Sequential designs Ovulation inhibition Investigators brochure Early phase Glaucoma DUS Paediatricians Patients DDI Post authorisation Informed Consent Procedure Edema Allergy Ophthalmology Inhalatives Design development Statistical services Experience Authorities First in human Axis Adrenocortical PASS IVIVC DFI MDI Biosimilars CRA Intensive assessment station GCP training Expert Ophthalmologist IB Pharmacokinetics ADAM Patient recruitment Pragmatism AGAH Phase III Immunogenicity OTC Transdermal therapeutic system Product development COPD Project Management Charcoal Central surveillance system Scientific advice Pilot study Ophthalmological trials Drug Food Interaction Phase I Phase IV SOP based Uveitis FIM Cardiovascular surveillance Database Sore throat US FDA Macular Steady state MCID Data Validation Plan Creativity SDV Lung Phase IIa trials Good Clinical Practice Thuringia Biopharmaceutics Protocol Training Clinical development program Standardisation Metered dose inhaler Xerostomia Biopharmaceutical Sensitisation trials Local tolerability WinNonlin SocraTec C&S Pharmacokintetics Slit lamp microscopy Ocular tolerability Source Data Verification IEC Highly variable drugs FDA Oncologic network Degeneration Quality Management System CDSIC Bioavailability Referral system IMPD Bioequivalence Asthma Rhine Main area CDISC Quality Assurance Non interventional Dry powder inhaler Life cycle management In vitro in vivo correlation ANVISA Absorption GLP Dermal irritation Efficacy Competence Quality HPA axis Clinical pharmacology unit Recruitment rates Legal representative Patch adhesion Spacious archive CRO Statistical programming Common cold Data Management Plan GCP EMA Protocol development Pharmacodynamic studies Copyright Postmenopausal women Pharmacology Inspection Network Sample size estimation Children Elpro Patch CDASH Monitoring Hypothalamic Subcontractor qualification Biometrics Pituitary Anaesthesiologist Legal Information Pulse oximetry plethysmography Drug Drug Interaction Dose linearity Female adolescents PAES Centralised procedure Statistical Analysis Plan Oncology Phase IIb trials DPI US CFR 21 Part 11 Clinical trials Audit TTS Oncological patients CRF HRT Hormone replacement therapy Dry eye  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page